Polymorhisms in the transforming growth factor-β1 gene (TGF-β1) and the risk of advanced alcoholic liver disease

Liver International

Volumn 25, Issue 5, 2005, Pages 935-939

  Oliver, Javier ^a   Agúndez, José A G ^b   Morales, Sonia ^a   Fernández Arquero, Miguel ^c   Fernández Gutierrez, Benjamín ^c   de la Concha, Emilio G ^c   Díaz Rubio, Manuel ^c   Martín, Javier ^a   Ladero, José M ^c  

^a CSIC   (Spain)

^b UNIVERSITY OF EXTREMADURA   (Spain)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Alcoholic cirrhosis; Ethanol abuse; Genetic polymorphism; Transforming growth factor

Indexed keywords

ALCOHOL; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ALCOHOL ABUSE; ALCOHOL LIVER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FIBROGENESIS; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSFORMING GROWTH FACTOR BETA1 GENE; GENETICS; GENOTYPE; HAPLOTYPE; MIDDLE AGED; SEXUAL DEVELOPMENT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENOTYPE; HAPLOTYPES; HUMANS; LIVER DISEASES, ALCOHOLIC; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; SEX CHARACTERISTICS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 26044469822     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2005.01150.x     Document Type: Article

References (26)

1. Kamper-Jørgensen M, Grønbaek M, Tolstrup J, Becker U. Alcohol and cirrhosis: dose-response or threshold effect? J Hepatol 2004; 41: 25-30.
2. Lelbach W K. Cirrhosis in the alcoholic and its relation to the volume of ethanol abuse. Ann NY Acad Sci 1975; 252: 85-105.
3. Bataller R, North K E, Brenner D A. Genetic polymorphisms and the progression of liver fibrosis: a critical appraisal. Hepatology 2003; 37: 493-503.
4. Sobeski R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, et al. Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group. Gastroenterology 1999; 116: 378-86.
5. Bedossa P, Paradis V. Transforming growth factor beta (TGF-beta): a key role in liver fibrogenesis. J Hepatol 1995; 22(suppl.): 37-42.
6. Chen W X, Li Y M, Yu C H, Cai W M, Zheng M, Chen F. Quantitative analysis of transforming growth factor beta 1 mRNA in patients with alcoholic liver disease. World J Gastroenterol 2002; 8: 379-81.
7. Yuen M F, Norris S, Evans L W, Laugley P G, Hughes R D. Transforming growth factor-beta 1, activin and follistatin in patients with hepatocellular carcinoma and patients with alcoholic cirrhosis. Scand J Gastroenterol 2002; 37: 233-8.
8. Santos R M, Norton P, Degli Esposti S, Zern M A. TGF-beta isoforms in alcoholic liver disease. J Gastroenterol 1998; 33: 383-9.
9. Flisiak R, Pytel-Krolczuc B, Prokopowicz D. Circulating transforming growth factor beta(1) as an indicator of hepatic function impairment in liver cirrhosis. Cytokine 2000; 12: 677-81.
10. Daniluk J, Szuster-cieselska A, Drabko J, Kandefer-Szarszen M. Serum cytokine levels in alcohol-related liver cirrhosis. Alcohol 2001; 23: 29-34.
11. Powell E E, Edwards-Smith C J, Hay J L, Clouston A D, Crawford D H, Shorthouse C, et al. Host genetic factors influence disease progression in chronic hepatitis C. Hepatology 2000; 31: 828-33.
12. Grainger D J, Heathcote K, Chiano M, Snieder H, Kemp P R, Metcalfe J C, et al. Genetic control of the circulating concentration of transforming growth factor type β1. Hum Mol Genet 1999; 8: 93-7.
13. Awad M R, El-Gamel A, Hasleton P, Turner D M, Sinnott P J, Hutchinson I V. Genotypic variation in the transforming growth factor-beta 1 gene: association with transforming growth factor-beta 1 production, fibrotic lung disease, and graft fibrosis after lung transplantation. Transplantation 1998; 66: 1014-20.
14. He B, Xu C, Tang B, Landtblom A M, Fredrikson S, Hillert J. Linkage and association analysis of gene encoding cytokine and myelin proteins in multiple sclerosis. J Neuroimmunol 1998; 86: 13-9.
15. Bathgate A J, Pravica V, Perrey C, Hayes P C, Hutchinson I V. Polymorphisms in tumour necrosis factor α, interleukin-10 and transforming growth factor β1 genes and end-stage liver disease. Eur J Gastroenterol Hepatol 2000; 12: 1329-33.
16. Lario S, Inigo P, Campistol J M, Poch E, Rivera F, Oppenheimer F. Restriction enzyme-based method for transforming growth factor-beta(1) genotyping: nonisotopic detection of polymorphisms in codons 10 and 25 and the 5′-flanking region. Clin Chem 1999; 45: 1290-2.
17. Macías M A, Rendón P, Navas C, Tejada M, Infantes J M, Martin L. Ultrasonography in patients with chronic liver disease: its usefulness in the diagnosis of cirrhosis. Rev Esp Enferm Dig 2003; 95: 258-64.
18. Tyndale R F. Genetics of alcohol and tobacco use in humans. Ann Med 2003; 35: 94-121.
19. Schneider A, Barmada M M, Slivka A, Martin J K, Whithcomb D C. Analysis of tumor necrosis factor-alpha, transforming growth factor-beta 1, interleukin-10, and interferon-gamma polymorphisms in patients with alcoholic chronic pancreatitis. Alcohol 2004; 32: 19-24.
20. Blobe G C, Schiemann W P, Lodish H F. Role of transforming growth factor β in human disease. N Engl J Med 2000; 342: 1350-8.
21. Oberhammer F, Nagy P, Tiefenbacher R, Fröschl G, Bouzahzah B, Thorgeisson S S, et al. The antiandrogen cyproterone acetate induces synthesis of transforming growth factor β1 in the parenchimal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation. Hepatology 1996; 23: 329-37.
22. Dixon J B, Bhathal P S, Jonsson J R, Dixon A F, Powell E E, O'brien P E. Pro-fibrotic polymorphisms predictive of advanced liver fibrosis in the severely obese. J Hepatol 2003; 39: 967-71.
23. Gewaltig J, Mangasser-Stephan K, Gartung G, Biesterfeld S, Gressner A M. Association of polymorphisms of the transforming growth factor-beta 1 gene with the rate of progression of HCV-induced liver fibrosis. Clin Chim Acta 2002; 316: 83-94.
24. Tag C G, Mengstead S, Hellerbrand C, Lammert F, Gressner A M, Weiskirchen R. Analysis of the transforming growth factor-beta1 (TGF-beta1) codon 25 gene polymorphism by LightCycler-analysis in patients with chronic hepatitis C infection. Cytokine 2003; 24: 173-81.
25. Barrett S, Collins M, Kenny C, Ryan E, Keane C O, Crowe J. Polymorphisms in tumour necrosis factor-alpha, transforming growth factor-beta, interleukin-10, interleukin-6, interferon gamma, and outcome of hepatitis C virus infection. J Med Virol 2003; 71: 212-8.
26. Suzuki S, Tanaka Y, Orito E, Sugauchi F, Hasegawa I, Sakurai M, et al. Transforming growth factor-beta-1 genetic polymorphism in Japanese patients with chronic hepatitis C virus infection. J Gastroenterol Hepatol 2003; 18: 1139-43.